These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23771560)

  • 21. Innate Cells: The Alternative Source of IL-17 in Axial and Peripheral Spondyloarthritis?
    Rosine N; Miceli-Richard C
    Front Immunol; 2020; 11():553742. PubMed ID: 33488572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extra-articular disease in patients with spondyloarthritis. Baseline characteristics of the spondyloarthritis cohort of the AQUILES study.
    Zarco P; González CM; Rodríguez de la Serna A; Peiró E; Mateo I; Linares L; Calvo J; Cea-Calvo L; Arteaga MJ; Vanaclocha F; Marín-Jiménez I; García-Vicuña R
    Reumatol Clin; 2015; 11(2):83-9. PubMed ID: 25441489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of spondyloarthritis.
    Breban M
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):593-9. PubMed ID: 16777584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis.
    Ceribelli A; Motta F; Vecellio M; Isailovic N; Ciccia F; Selmi C
    Front Immunol; 2021; 12():622770. PubMed ID: 34149686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A family-based genome-wide association study reveals an association of spondyloarthritis with MAPK14.
    Costantino F; Talpin A; Said-Nahal R; Leboime A; Zinovieva E; Zelenika D; Gut I; Charon C; Izac B; Weissman M; Chiocchia G; Reveille J; Breban M; Garchon HJ
    Ann Rheum Dis; 2017 Jan; 76(1):310-314. PubMed ID: 27461236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics: An Emerging Approach to Understand Pathogenesis and to Assess Diagnosis and Response to Treatment in Spondyloarthritis.
    Rizzo C; Camarda F; Donzella D; La Barbera L; Guggino G
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of comorbidities in spondyloarthritis including psoriatic arthritis.
    Scriffignano S; Perrotta FM; De Socio A; Lubrano E
    Clin Rheumatol; 2019 Jan; 38(1):3-10. PubMed ID: 30338414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study.
    Sieper J; Srinivasan S; Zamani O; Mielants H; Choquette D; Pavelka K; Loft AG; Géher P; Danda D; Reitblat T; Cantini F; Ancuta C; Erdes S; Raffayová H; Keat A; Gaston JS; Praprotnik S; Vastesaeger N
    Ann Rheum Dis; 2013 Oct; 72(10):1621-7. PubMed ID: 23065731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the Pathogenesis of Spondyloarthritis.
    Sharip A; Kunz J
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33092023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Biology Approaches to Understanding Spondyloarthritis.
    Berlinberg A; Kuhn KA
    Rheum Dis Clin North Am; 2020 May; 46(2):203-211. PubMed ID: 32340696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Extra-articular manifestations of seronegative spondyloarthritides].
    Morović-Vergles J; Culo MI
    Reumatizam; 2011; 58(2):54-6. PubMed ID: 22232949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
    Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
    Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of Axial Spondyloarthritis - Sources and Current State of Knowledge.
    Ermann J
    Rheum Dis Clin North Am; 2020 May; 46(2):193-206. PubMed ID: 32340695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis.
    Gravallese EM; Schett G
    Nat Rev Rheumatol; 2018 Nov; 14(11):631-640. PubMed ID: 30266977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the genetics of spondyloarthritis--ankylosing spondylitis and psoriatic arthritis.
    Chandran V; Rahman P
    Best Pract Res Clin Rheumatol; 2010 Oct; 24(5):579-88. PubMed ID: 21035081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The concept of spondyloarthritis: where are we now?
    Garg N; van den Bosch F; Deodhar A
    Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):663-72. PubMed ID: 25488776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriatic arthritis and spondyloarthritis assessment and management update.
    Mease P
    Curr Opin Rheumatol; 2013 May; 25(3):287-96. PubMed ID: 23492739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis.
    Chou CT
    Clin Dev Immunol; 2013; 2013():369202. PubMed ID: 23840241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid treatment in spondyloarthritis.
    Fendler C; Baraliakos X; Braun J
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S139-42. PubMed ID: 22018200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study.
    Lindström U; Bremander A; Haglund E; Bergman S; Petersson IF; Jacobsson LT
    BMC Musculoskelet Disord; 2016 Feb; 17():106. PubMed ID: 26922375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.